| Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma N Mishra, S Kumar, S Singh, T Bansal, N Jain, S Saluja, R Kumar, ... PLoS Pathogens 17 (9), e1009958, 2021 | 27 | 2021 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 108020, 2021 | 18 | 2021 |
| An overview of human anti-HIV-1 neutralizing antibodies against diverse epitopes of HIV-1 S Kumar, S Singh, K Luthra ACS omega 8 (8), 7252-7261, 2023 | 15 | 2023 |
| The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41 R Perween, M PraveenKumar, T Shrivastava, HA Parray, V Singh, ... International Immunopharmacology 101, 108187, 2021 | 7 | 2021 |
| Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children S Kumar, H Batra, S Singh, H Chawla, R Singh, S Katpara, AW Hussain, ... Journal of General Virology 101 (12), 1289-1299, 2020 | 4 | 2020 |
| Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody S Kumar, S Singh, A Chatterjee, P Bajpai, S Sharma, S Katpara, R Lodha, ... Iscience 26 (9), 2023 | 3 | 2023 |
| Plasma neutralizing antibodies in an infant with interclade HIV-1 superinfection preferentially neutralize superinfecting HIV-1 strains N Mishra, S Sharma, A Dobhal, S Kumar, H Chawla, S Singh, R Singh, ... bioRxiv, 2020.12. 10.420703, 2020 | 1 | 2020 |
Kalpana LuthraProfessor of Biochemistry, All India Institute of Medical SciencesVerified email at aiims.ac.in
